Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients ...

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

Treatment of hypertensive retinopathy begins with controlling hypertension. Some of the complications can be treated by an ophthalmologist with injectable medications into the eye as well as laser ...

Tingling nerves and slow-healing sores are more common in type 2. Left untreated, type 1, in particular, can lead to diabetic ketoacidosis. This is when there is a dangerous level of ketones in ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading the Flagship-founded biotech to drop the candidate.

Abstract: Diabetic retinopathy (DR) is a severe complication of diabetes that affects the retinal structures and can lead to significant visual impairment or even blindness. Early diagnosis is crucial ...

This condition is called diabetic ketoacidosis. It’s a medical emergency and requires immediate medical treatment. Symptoms of type 2 diabetes tend to come on more gradually than type 1 diabetes.

From Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Victoria, Australia (R.H.R.) Division of Endocrinology and Metabolism (E.D.A.), ...

HealthDay News — Empagliflozin initiation is not associated with incident nonproliferative diabetic retinopathy (NPDR) compared with initiation of a dipeptidyl peptidase 4 inhibitor (DPP4i), according ...

Diabetic retinopathy (DR) remains the leading cause of vision loss and blindness in people of working age, in spite of the fact that current treatments are effective. Vision loss occurs in DR due ...

TUESDAY, Dec. 17, 2024 (HealthDay News) -- Empagliflozin initiation is not associated with incident nonproliferative diabetic retinopathy (NPDR) compared with initiation of a dipeptidyl peptidase ...